Literature DB >> 22194397

Nuclear JAK2.

Mark A Dawson, Andrew J Bannister, Lindsay Saunders, Omar-Abdel Wahab, Fan Liu, Stephen D Nimer, Ross L Levine, Berthold Göttgens, Tony Kouzarides, Anthony R Green.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22194397      PMCID： PMC4729533          DOI： 10.1182/blood-2011-10-385278

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  15 in total

1.  Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling.

Authors:  Sachiko Kamakura; Koji Oishi; Takeshi Yoshimatsu; Masato Nakafuku; Norihisa Masuyama; Yukiko Gotoh
Journal:  Nat Cell Biol       Date:  2004-05-23       Impact factor: 28.824

2.  Kinase activity and subcellular distribution of a chimeric green fluorescent protein-tagged Janus kinase 2.

Authors:  Sheeyong Lee; Roy J Duhé
Journal:  J Biomed Sci       Date:  2006-09-14       Impact factor: 8.410

Review 3.  Epitope tagging.

Authors:  J W Jarvik; C A Telmer
Journal:  Annu Rev Genet       Date:  1998       Impact factor: 16.830

4.  Confocal imaging studies cast doubt on nuclear localization of JAK2V617F.

Authors:  François Girodon; Mara P Steinkamp; Cédric Cleyrat; Sylvie Hermouet; Bridget S Wilson
Journal:  Blood       Date:  2011-09-01       Impact factor: 22.113

Review 5.  Nuclear JAK2: form and function in cancer.

Authors:  Cui-Juan Qian; Jun Yao; Jian-Min Si
Journal:  Anat Rec (Hoboken)       Date:  2011-08-01       Impact factor: 2.064

6.  Controlling nuclear JAKs and STATs for specific gene activation by IFNγ.

Authors:  Ezra N Noon-Song; Chulbul M Ahmed; Rea Dabelic; Johnathan Canton; Howard M Johnson
Journal:  Biochem Biophys Res Commun       Date:  2011-06-13       Impact factor: 3.575

7.  JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation.

Authors:  Fan Liu; Xinyang Zhao; Fabiana Perna; Lan Wang; Priya Koppikar; Omar Abdel-Wahab; Michael W Harr; Ross L Levine; Hao Xu; Ayalew Tefferi; Anthony Deblasio; Megan Hatlen; Silvia Menendez; Stephen D Nimer
Journal:  Cancer Cell       Date:  2011-02-15       Impact factor: 31.743

8.  Constitutive nuclear localization of Janus kinases 1 and 2.

Authors:  P E Lobie; B Ronsin; O Silvennoinen; L A Haldosén; G Norstedt; G Morel
Journal:  Endocrinology       Date:  1996-09       Impact factor: 4.736

9.  LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease.

Authors:  Dean S Griffiths; Juan Li; Mark A Dawson; Matthew W B Trotter; Yi-Han Cheng; Aileen M Smith; William Mansfield; Pentao Liu; Tony Kouzarides; Jennifer Nichols; Andrew J Bannister; Anthony R Green; Berthold Göttgens
Journal:  Nat Cell Biol       Date:  2010-12-12       Impact factor: 28.824

10.  JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin.

Authors:  Mark A Dawson; Andrew J Bannister; Berthold Göttgens; Samuel D Foster; Till Bartke; Anthony R Green; Tony Kouzarides
Journal:  Nature       Date:  2009-09-27       Impact factor: 49.962
View more
  3 in total

1.  JAK2 tyrosine kinase phosphorylates and is negatively regulated by centrosomal protein Ninein.

Authors:  Jennifer Jay; Alan Hammer; Andrea Nestor-Kalinoski; Maria Diakonova
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

2.  Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation.

Authors:  Ze-Yi Zheng; Lin Tian; Wen Bu; Cheng Fan; Xia Gao; Hai Wang; Yi-Hua Liao; Yi Li; Michael T Lewis; Dean Edwards; Thomas P Zwaka; Susan G Hilsenbeck; Daniel Medina; Charles M Perou; Chad J Creighton; Xiang H-F Zhang; Eric C Chang
Journal:  Cell Rep       Date:  2015-07-09       Impact factor: 9.423

3.  The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia.

Authors:  Dagmar Schinnerl; Klaus Fortschegger; Maximilian Kauer; João R M Marchante; Reinhard Kofler; Monique L Den Boer; Sabine Strehl
Journal:  Blood       Date:  2014-12-16       Impact factor: 22.113
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.